Redhill Biopharma Ltd (NASDAQ:RDHL)

7.09
Delayed Data
As of May 25
 -0.02 / -0.28%
Today’s Change
4.30
Today|||52-Week Range
11.25
+37.94%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close7.11
Today’s open7.07
Day’s range7.01 - 7.11
Volume7,936
Average volume (3 months)93,440
Market cap$146.8M
Data as of 3:59pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)-13.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,882.91%
P/E ratioNM
Price/Sales22.49
Price/Book3.25

Competitors

 Today’s
change
Today’s
% change
TRVNTrevena Inc+0.02+1.16%
REPHRecro Pharma Inc-0.08-1.42%
CDMOAvid Bioservices Inc-0.06-1.74%
ACRXAcelRx Pharmaceutica...-0.20-5.88%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateJuly 24, 2018
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$4.0M
Annual profit (last year)-$45.9M
Net profit margin-1,136.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Chief Operating Officer
Gilead Raday
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts